Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Medshine Discovery Inc.

Nanjing Sanhome Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Guangdong Zhongsheng Pharmaceutical Co., Ltd

Baoping Zhao

Shuhui Chen

Jian Li

Fei Wang

Charles Z Ding

Xile Liu

Chao Ding

Linxia Xiao

Long Zhang

Zhaozhong Ding

Zhaobing Xu

Yingchun Liu

Haiwen Wan

Minghui Zhang

Chuanwen Fan

Ruibin Lin

Yingying Yang

Yidong Zhu

Jinqing Hu

Shansong Zheng

Qingmei Zheng

Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound represented by formula (I) and used as an EGFR inhibitor or a pharmaceutically acceptable salt thereof. 

Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor

Disclosed is a spirocyclic aryl phosphorus oxide or sulfide as an ALK inhibitor, particularly, a compound represented by formula (I) as an ALK inhibitor or pharmaceutically acceptable salt thereof. 

Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide

Disclosed is a substituted 2H-pyrazole derivative serving as a selective CDK4/6 inhibitor. Specifically, disclosed is a compound of formula (I) or a pharmaceutically acceptable salt thereof which serves as a selective CDK4/6 inhibitor. 

Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug

Growing community of inventors

Shanghai, China

Baoping Zhao